Arcus Biosciences
RCUS
RCUS
92 hedge funds and large institutions have $375M invested in Arcus Biosciences in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
0.37% less ownership
Funds ownership: 59.1% → 58.73% (-0.37%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Holders
92
Holding in Top 10
4
Calls
–
Puts
$8K
Top Buyers
| 1 | +$19.6M | |
| 2 | +$11.2M | |
| 3 | +$6.32M | |
| 4 |
Millennium Management
New York
|
+$4.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.97M |
Top Sellers
| 1 | -$49.1M | |
| 2 | -$6.08M | |
| 3 | -$3.17M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.99M |
| 5 |
JPMorgan Chase & Co
New York
|
-$1.11M |